Cardiology Private Equity Offers: Key Terms to Review
Cardiology private equity interest has grown as investor-backed platforms look to add independent groups, imaging services and other ancillary lines. For many practice owners, the first sign of that interest is an unsolicited letter or a call asking whether they would consider a partnership.
An offer can be attractive, but the headline number rarely tells the whole story. This article walks through the key terms independent cardiologists should review and the alternatives they may want to compare. Transaction structures, ownership rules and tax treatment vary by state and deal, and nothing here is legal, tax, billing or compliance advice. Owners should involve healthcare counsel, accountants and other qualified advisors before signing anything.
How Cardiology Private Equity Deals Are Typically Structured
Most investor transactions in physician practices separate the clinical practice from the business operations. Because many states restrict who may own a medical practice, the investor often acquires the non-clinical assets and enters into a long-term management services agreement with the physician-owned practice. Whether and how that structure works in your state is a question for counsel.
In exchange, the selling physicians usually receive some combination of:
- Cash at closing
- Rollover equity in the investor’s platform company
- An employment or professional services agreement
- A share of future earnings through a revised compensation model
Key Terms to Review in a Letter of Intent
Purchase Price and the Earnings Base
Offers are usually based on a normalized earnings figure. Understand exactly how that figure was calculated, which add-backs were accepted and how ancillary revenue was treated. Our article on cardiology practice valuation explains what drives those numbers.
Compensation Reduction
Many structures pay physicians less after closing than they earned as owners, with the difference flowing to the platform. That reduction is often what funds the purchase price. Owners should model their expected income over the length of the employment agreement and compare it with what they would earn by staying independent.
Cash Versus Rollover Equity
The share of the price paid in cash at closing versus rollover equity affects both risk and potential upside. Rollover value depends on the platform’s future performance and an eventual sale that is not assured. Our article on cardiology rollover equity covers that topic in depth.
Earnouts and Holdbacks
Some offers hold back part of the price or tie it to future performance. Understand what triggers payment, who controls the metrics and what happens if you leave or the platform changes strategy.
Employment Terms and Restrictive Covenants
Review the length of the employment agreement, productivity expectations, call requirements, termination provisions and non-compete terms. Enforceability of restrictive covenants varies by state and should be reviewed by counsel.
Governance and Clinical Autonomy
Ask who will make decisions about hiring, equipment purchases, scheduling, payer contracting and new locations. Understand what clinical decisions remain with physicians and how disputes are resolved.
Ancillary Services and Real Estate
Imaging, monitoring and other ancillary lines are often central to how a platform values a cardiology group. Clarify which ancillary entities are included, how their earnings are counted and whether the practice’s real estate is part of the deal or will be leased back. If physicians own the building, a lease negotiated at closing can affect rental income for years.
Impact on Younger Physicians
Partners near retirement and physicians early in their careers may view the same offer differently. Younger cardiologists may give up years of ownership income in exchange for a share of the proceeds. Groups should consider how the offer affects every partner, including future associates.
Alternatives to a Private Equity Sale
An investor offer is one option, not the only one. Depending on the practice, alternatives may include:
- Staying independent: continuing to own the practice and keep its full earnings
- Bank-financed partner buyouts: allowing retiring partners to exit while remaining partners keep ownership, as described in our article on cardiology partner buyout financing
- Recapitalization with debt: using lender financing to provide some liquidity to owners while keeping control within the group
- Sale to another physician group: which may offer different terms and cultural fit
- Hospital alignment: which carries its own trade-offs and should be compared carefully
Each option has different implications for income, control and long-term value. Debt-financed alternatives depend on the practice’s cash flow, the borrowers, use of proceeds and lender review, and every loan is subject to approval.
Questions to Ask Before Signing
- What will I receive in cash at closing after taxes and fees?
- What will my income be each year under the new compensation model?
- How is rollover equity valued, and when can it be sold?
- What happens if I leave early, become disabled or retire?
- Who controls equipment replacement and ancillary service decisions?
- How will the group recruit and compensate new physicians?
Preparing Before You Respond
Owners who prepare before entering talks are usually in a stronger position. Cleaning up financial statements, documenting add-backs and understanding your own valuation can help you evaluate any offer. Our guide on how to prepare a cardiology practice for sale walks through those steps, and our advisory and consulting services can help owners think through valuation, sale and succession questions.
Final Thoughts
Cardiology private equity offers can provide liquidity and access to resources, but they also change how physicians are paid and how decisions are made. Reviewing the earnings base, compensation reduction, rollover equity, employment terms and governance, and comparing the offer with independent alternatives, can help owners make a decision that fits their goals.
US Medical Funding helps cardiology groups explore financing alternatives, including partner buyouts and recapitalizations. Learn more about our middle-market healthcare financing and our full range of cardiology practice financing options.
